RSSВерсія для друку
Kashyntseva O. J., Trofymenko M. M.


Med. pravo., 2020; 2(26): 34-48

UDС: 347.45

Kashyntseva Oksana Yuriyivna

Candidate of Law, Associate Professor, Head of the Harmonization Center
human rights and intellectual property rights of the Research
Institute of Intellectual Property of the National Academy of Law
Sciences of Ukraine

Trofymenko Mykyta Mykhaylovych

Master of Law, Legal Adviser of the Charitable Organization "100% of Life"

Legal measures to expend the access to treatment duringthe pandemic in Ukraine and in the world

The article concerns the comparative legal analysis of managed entryagreements (MEAs), compulsory licenses on inventions and the use of pat-ented inventions without the permission of an owner of the patent rights in order to ensure the health of the population and in emergency circum-stances. The authors determine the essential conditions and special fea-tures of such agreements. In article the authors present the analysis of theinternational legal regulation of the market of patent rights in the field ofpharmacy. Managed entry agreements are the effective legal instrumentfor ensuring access to innovative medicines, which are still in the post-clin-ical stage, while the compulsory licensing and the government use in thepublic interests could expand access to generic versions of medicines. All ofmentioned legal measures are available in Ukrainian legislation, but noneof them has been used yet.Key words: managed entry agreements, compulsory licenses, govern-ment use, intellectual property, human rights, access to medicines.

Reference list:

1.  United Nations Millennium Development Goals, 2000. Retrieved from

2.  The Global Strategy and Plan of Action on Public Health, Innovation and IntellectualProperty. Retrieved from

3. Kashyntseva O., Trofymenko M. Zastosuvannia likiv off-labele ta nezareiestrovanykh likarskykh zasobiv kriz pryzmu prava intelektualnoi vlasnosti:perspektyvy dlia svitu ta Ukrainy. Retrieved from

4.  International Federation of Library Associations and Institutions. Retrieved from

5.  Médecins Sans Frontières. Retrieved from

6. Osnovy zakonodavstva Ukrainy pro okhoronu zdorovia : Zakon Ukrainy vid 19.11.1993. URL:

7.  Pro vnesennia zmin do deiakykh zakonodavchykhaktiv Ukrainy (shchodo reformy patentnoho zakonodavstva) : Zakon Ukrainy vid 21.07.2020. Retrieved from

8.  Pro likarski zasoby : Zakon Ukrainy vid4.04.1996. Retrieved from

9. Kruhlyi stil «Dohovir kerovanoho dostupu ta prymusove litsenzuvannia yak instrumentyrozshyrennia dostupu do likuvannia» 24.07.2020. Retrieved from 

10.  Pauwels K., Huys I., Vogler S., Casteels M., Simoens S. Managed Entry Agreementsfor Oncology Drugs: Lessons from the European Experience to Inform the Future. URL:

11. Paryzka konventsiia pro okhoronu promyslovoivlasnosti vid 20.03.2020. Retrieved from

12.  Uhoda pro torhоvelni aspektyprav intelektualnoi vlasnosti vid 15.04.1994. Retrieved from

13.  Uhoda proasotsiatsiiu mizh Ukrainoiu, z odniiei storony, ta Yevropeiskym Soiuzom, Yevropeiskymspivtovarystvom z atomnoi enerhii i yikhnimy derzhavamy-chlenamy, z inshoi storony, vid27.06.2014. Retrieved from

14. FAIR Health. The Projected Economic Impact of the COVID-19 Pandemic on theUS Healthcare System. New York: FAIR Health, Inc.; 2020. Retrieved from

15. Kass D. Israel Defies AbbVie IP To Import Generic Drugs For COVID-19. March19, 2020. Retrieved from Accessed:March 24, 2020.

16. COVID-19 Emergency Response Act, S.C. 2020, C-13 (Can.). Gesetz zum Schutzder Bevölkerung bei einer epidemischen Lage von nationaler Tragweite. Retrieved from